Lisdexamfetamine: all 97 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 DiabetesRecruitingNCT05957055Phase 2
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)CompletedNCT04599504Phase 2/3Results posted
- Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance TreatmentCompletedNCT03926052Phase 3Results posted
- Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute TreatmentCompletedNCT03924193Phase 3Results posted
- Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHDCompletedNCT03446885Phase 4Results posted
- Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)CompletedNCT03260205Phase 3Results posted
- IMProving Executive Function StudyCompletedNCT03187353Phase 4Results posted
- Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in ChildrenCompletedNCT02712996Phase 4Results posted
- Shire SCT: Lisdexamfetamine Treatment for ADHD and SCTCompletedNCT02635035Phase 2Results posted
- Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity DisorderCompletedNCT02466386Phase 3Results posted
- Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity DisorderCompletedNCT02402166Phase 2Results posted
- An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHDTerminatedNCT02259517Not applicableResults posted
- Lisdexamfetamine's Effect In ADHD in the Brain and CognitionTerminatedNCT02170298Phase 4Results posted
- Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCompletedNCT02009163Phase 3Results posted
- LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal WomenCompletedNCT01977625Phase 4Results posted
- Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain ActivationCompletedNCT01924429Phase 4Results posted
- Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult VolunteersCompletedNCT01890785Phase 1Results posted
- Sequencing Treatments for Mothers With ADHD and Their At - Risk ChildrenCompletedNCT01816074Phase 4Results posted
- Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaTerminatedNCT01760993Phase 3Results posted
- SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaTerminatedNCT01760889Phase 3Results posted
- Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of SchizophreniaTerminatedNCT01738698Phase 3Results posted
- SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCompletedNCT01718509Phase 3Results posted
- SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCompletedNCT01718483Phase 3Results posted
- Open Label Extension in Adults With Binge Eating Disorder (BED)CompletedNCT01657019Phase 3Results posted
- Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple SclerosisCompletedNCT01615887Phase 2Results posted
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderCompletedNCT01552915Phase 4Results posted
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderCompletedNCT01552902Phase 4Results posted
- Open-Label Pilot Study of Lisdexamfetamine for Cocaine DependenceCompletedNCT01486810Phase 1/2Results posted
- Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With SchizophreniaCompletedNCT01457339Phase 1Results posted
- SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyTerminatedNCT01436175Phase 3Results posted
- Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01436162Phase 3Results posted
- Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01436149Phase 3Results posted
- SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01435759Phase 2Results posted
- Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHDCompletedNCT01415440Not applicableResults posted
- Effects of LDX on Functioning of College Students With ADHDCompletedNCT01342445Phase 4Results posted
- Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT01328756Phase 4Results posted
- Attention & Memory Impairments in Menopausal WomenCompletedNCT01324024Phase 4Results posted
- Forced-dose Titration of SPD489 in Adults With Binge Eating DisorderCompletedNCT01291173Phase 2Results posted
- Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.CompletedNCT01148979Phase 4Results posted
- Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?CompletedNCT01127607Phase 4Results posted
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to MethylphenidateCompletedNCT01106430Phase 3Results posted
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT01101022Phase 4Results posted
- Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep LossCompletedNCT01096680Phase 2Results posted
- Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue SyndromeCompletedNCT01071044Phase 4Results posted
- Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)CompletedNCT01070394Phase 4Results posted
- Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar DepressionTerminatedNCT01051440Phase 4Results posted
- Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and ObesityTerminatedNCT01017263Phase 4Results posted
- Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT01010750Phase 1Results posted
- Treatment of Traumatic Brain Injury (TBI)-Related Attention DeficitsTerminatedNCT01000064Phase 3Results posted
- SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive DisorderCompletedNCT00985725Phase 2Results posted
- Treatment of Cocaine Dependence With LisdexamfetamineCompletedNCT00958282Phase 2Results posted
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative SymptomsCompletedNCT00922272Phase 2Results posted
- A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy VolunteersCompletedNCT00919867Phase 1Results posted
- Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an AntidepressantCompletedNCT00905424Phase 2Results posted
- Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)CompletedNCT00889915Phase 4Results posted
- Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity DisorderCompletedNCT00877487Phase 4Results posted
- Effect of Vyvanse on Driving in Young Adults With ADHDCompletedNCT00801229Phase 4Results posted
- Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17CompletedNCT00784654Phase 3Results posted
- Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral SolutionTerminatedNCT00776555Phase 1Results posted
- Vyvanse Adolescent Open-Label Safety and Efficacy Extension StudyCompletedNCT00764868Phase 3Results posted
- Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17CompletedNCT00763971Phase 3Results posted
- Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder AdultsCompletedNCT00753012Phase 4Results posted
- Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTCCompletedNCT00746733Phase 1Results posted
- Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation StudyCompletedNCT00736255Not applicableResults posted
- Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00735371Phase 3Results posted
- The Effects of Vyvanse(TM) on Brain Hemodynamics and ReadingCompletedNCT00733356Phase 4Results posted
- Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT00697515Phase 3Results posted
- Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance AbuseCompletedNCT00573534Phase 4Results posted
- A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00500149Phase 3Results posted
- Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHDCompletedNCT00500071Phase 4Results posted
- An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00337285Phase 3Results posted
- To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions.CompletedNCT07098585Phase 1
- Vyvanse in Children Aged 6 to 12 YearsCompletedNCT05416125Early Phase 1
- Effects of LDX on Cognitive Processes and AppetiteTerminatedNCT04181957Not applicable
- Lisdexamfetamine for Adults With Bulimia NervosaTerminatedNCT03397446Phase 2
- Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and AutismCompletedNCT03337646Phase 4
- Experimental fMRI Study of Guanfacine and Lisdexamfetamine in ADHD AdolescentsCompletedNCT03333668Not applicable
- Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery PatientsStatus unknownNCT03070509Phase 4
- Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)CompletedNCT02675400Phase 4
- Lisdexamfetamine in Binge Eating Disorder (BED): fMRI EffectsStatus unknownNCT02659488Phase 2
- A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHDCompletedNCT02555150Phase 3
- Clinical Efficacy of Lisdexamfetamine for Methamphetamine DependenceCompletedNCT02034201Phase 1
- LDX for the Treatment of Cognitive Functioning Issues in Women Post-OophorectomyWithdrawnNCT01986777Not applicable
- E2 and LDX for the Treatment of Cognitive Complaints After OophorectomyWithdrawnNCT01986764Not applicable
- Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder ComorbidityCompletedNCT01863459Phase 4
- Pilot Study of Lisdexamfetamine for Treatment of Cocaine DependenceTerminatedNCT01490216Phase 1
- Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)WithdrawnNCT01274221Phase 3
- SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of SchizophreniaWithdrawnNCT01234298Phase 3
- Adjunctive Lisdexamfetamine (LDX) in Bipolar DepressionTerminatedNCT01131559Phase 3
- Efficacy Study of Lisdexamfetamine to Treat Bipolar DepressionTerminatedNCT01093963Phase 3
- Efficacy Study of Lisdexamfetamine to Treat Binge Eating DisorderCompletedNCT01090713Phase 3
- Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00807222Not applicable
- NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHDCompletedNCT00557011Phase 2
- Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHDCompletedNCT00556296Phase 3
- Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT00334880Phase 3
- Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant AbuseCompletedNCT00248092Phase 1/2
- Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse HistoriesCompletedNCT00247572Phase 2